Hospital General de México Dr. Eduardo Liceaga   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Mexico City Mexico (1567)

Organization Overview

First Clinical Trial
2014
NCT02235519
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital General de Mexico Dr Eduardo Liceaga | Hospital General de Mexico Dr. Eduardo Liceaga | Hospital General de México Dr. Eduardo Liceaga | Hospital General de Mexico Eduardo Liceaga

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Glucose Intolerance (Phase 4)

Hypersensitivity (Phase 4)

Hypertension (Phase 3)

Insulin Resistance (Phase 4)

Kidney Diseases (Phase 4)

Obesity (Phase 3)

Pneumonia (Phase 2)

Prediabetic State (Phase 4)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12